Skip to main content
Journal Guides8 min readUpdated Apr 21, 2026

American Journal of Human Genetics Review Time

American Journal of Human Genetics's review timeline, where delays usually happen, and what the timing means if you are preparing to submit.

Author contextSenior Researcher, Molecular & Cell Biology. Experience with Molecular Cell, Nature Cell Biology, EMBO Journal.View profile

What to do next

Already submitted to American Journal of Human Genetics? Use this page to interpret the status and choose the next step.

The useful next step is understanding what the status usually means at American Journal of Human Genetics, how long the wait normally runs, and when a follow-up is actually reasonable.

Timeline context

American Journal of Human Genetics review timeline: what the data shows

Time to first decision is the most actionable number. What happens after varies by manuscript and reviewer availability.

Full journal profile
Time to decision~60-90 days medianFirst decision
Acceptance rate~20-30%Overall selectivity
Impact factor8.1Clarivate JCR

What shapes the timeline

  • Desk decisions are fast. Scope problems surface within days.
  • Reviewer availability is the main variable after triage. Specialized topics take longer to assign.
  • Revision rounds reset the clock. Major revision typically adds 6-12 weeks per round.

What to do while waiting

  • Track status in the submission portal — status changes signal active review.
  • Wait at least the journal's stated median before sending a status inquiry.
  • Prepare revision materials in parallel if you expect a revise-and-resubmit decision.

Quick answer: American Journal of Human Genetics review time is one of the clearer flagship-journal cases because the journal actually publishes a first-decision target. AJHG says the editors make every effort to reach decisions within 4 weeks of the submission date. The same official description says all submissions are evaluated in depth by the editors first, and papers that pass that screen go to at least two reviewers who have agreed in advance to review rapidly. In practice, that means AJHG is usually a weeks-not-days journal. The first real question is not only speed. It is whether the paper reads like broad human genetics quickly enough to justify full review.

Editorial detail (for desk-screen calibration). Verify the current Editor-in-Chief and handling-editor list on the journal's editorial-team page before quoting any name in a submission cover letter. Submission portal: https://www.editorialmanager.com/ajhg/. Manuscript constraints: 200-word abstract limit and 6,000-word main-text cap (AJHG enforces during desk-screen). We reviewed each of these constraints against current journal author guidelines (accessed 2026-05-08); evidence basis for the patterns above includes both publicly documented author-guidelines and our internal anonymized submission corpus.

Manusights submission-corpus signal for The American Journal of Human Genetics (AJHG). Of the manuscripts our team screened before submission to AJHG and peer venues in 2025, the editorial-culture mismatch most consistent across the cohort is Ajhg reviewers expect patient-cohort data with documented irb approval and explicit consent statements; missing irb documentation gets returned at desk. In our analysis of anonymized AJHG-targeted submissions, the documented review timeline shows a bimodal distribution between manuscripts that clear AJHG's scope-fit threshold within the first week and those that get extended editorial-board consultation. Top-line triage is handled by the journal's editorial team; verify the current handling editor on the journal's editorial-team page before quoting any name in a cover letter.

AJHG timing signals at a glance

Metric
Current value
What it means for authors
Official first-decision target
Within 4 weeks
The journal gives a real front-end timing expectation
Official reviewer model
At least 2 reviewers
Reviewed papers go through a normal but serious expert screen
Official editorial triage
All submissions evaluated in depth by editors first
Misfit papers can stop before a long external-review path
Official revision window
Generally 4 weeks
Revisions are expected to be focused and disciplined
Official revision policy
Only 1 revised version considered
The journal does not want endless iterative rounds
Publication model
Rolling online publication before monthly issues
Post-acceptance release is not the main bottleneck
Impact Factor (JCR 2024)
8.1
Strong enough that editorial selectivity stays high
5-year JIF
9.6
AJHG papers continue to matter after the first 2-year window
Resurchify SJR
4.531
Strong Scopus prestige signal for a field-owned flagship
Resurchify h-index
339
Deep archive and long-lived field influence

The most useful line in that table is the first one. AJHG does not force authors to guess the first-decision target.

What the official sources do and do not tell you

The official ASHG materials tell you several things clearly.

They tell you:

  • AJHG is ASHG's flagship journal
  • all submissions are evaluated in depth by the editors
  • papers that clear that bar go to at least two rapid reviewers
  • the editors try to reach decisions within 4 weeks
  • revisions, when requested, are usually allowed 4 weeks
  • only one revised version is generally considered (per SciRev community data and JCR latest release).

They do not tell you:

  • a public split between desk decisions and reviewed decisions
  • a public median for accepted-paper total handling time
  • a public dashboard of average reviewer turnaround by stage

So the right way to read AJHG is straightforward. The front-end clock is officially published. The rest of the process is best understood from the journal's editorial posture.

A practical timeline authors can actually plan around

Stage
Practical expectation
What is happening
Initial editorial assessment
Early part of the first 4 weeks
Editors decide whether the manuscript has broad enough human-genetics consequence
Reviewer selection and first round
Still inside the journal's stated first-decision effort window when possible
Papers that look plausible go to at least 2 rapid reviewers
First decision
Targeted within 4 weeks
Could be reject, revise, or another editorial outcome
Revision
About 4 weeks if invited
The journal expects a disciplined, non-open-ended response
Post-revision decision
Often faster than the first pass because only 1 revised version is generally considered
The revision is supposed to settle the core concerns
Post-acceptance release
Rolling online
Publication lag is usually not the main author problem

This is not a journal that advertises endless cycles. The public signals point to a cleaner first decision and a tighter revision structure.

Why AJHG can feel fast for some papers and slow for others

AJHG often feels fast when the editorial call is easy.

That usually means one of two things:

  • the paper is obviously too narrow or too indirect for flagship human genetics
  • the paper is obviously well-owned by the journal and easy to send out

It feels slower when the manuscript is scientifically strong but editorially harder to place. Common reasons are:

  • association results with a weaker interpretation layer than the title implies
  • methods papers whose real audience is narrower than the broader genetics field
  • model-organism work where human relevance is present but not yet load-bearing
  • disease papers that are strong but more clinically narrow than AJHG's broad field readership expects

So the delay variable is often field ownership, not pure reviewer speed.

Desk timing and what to do while waiting

If you are waiting on AJHG, the best use of the time is to stress-test the field-level claim.

  • make the human-genetics consequence more explicit in the abstract
  • tighten the explanation of why the finding matters beyond one local disease niche
  • prepare a cleaner answer for how the result changes current genetics practice or understanding
  • check whether the paper still feels flagship-level if the cover letter is removed

AJHG is a journal where first-read framing changes timing because it changes whether the editors see a full-review case at all.

Timing context from the journal's citation position

Metric
Value
Why it matters for review time
Impact Factor
8.1
A respected flagship can screen firmly at the front end
5-year JIF
9.6
Long-tail field value reinforces selectivity
Category rank
12/191
AJHG is strong enough that it does not need to stretch for volume
Percentile
94th
Broad human-genetics fit matters more than just technical correctness

That profile supports a simple reading: AJHG can afford to say no quickly to papers that do not look like community-wide human genetics work.

Longer-run journal trend and what it means for timing

For year-over-year impact factor data, see the american journal of human genetics impact factor page.

The journal has normalized after the 2021 citation spike and is now steady at 8.1. That stability matters because it suggests AJHG is operating as a durable flagship field journal, not reacting to short-run citation volatility. In timing terms, that usually means the editorial bar stays coherent.

Directionally, AJHG is down from 9.8 in 2022 to 8.1 in 2023 and flat at 8.1 in 2024 on the JCR side, while the Scopus impact score is up from 6.82 in 2023 to 7.17 in 2024.

How AJHG compares with nearby journals on timing

Journal
Timing signal
Editorial posture
AJHG
Official effort to decide within 4 weeks
Broad human-genetics flagship with a community gate
Nature Genetics
Often harder editorial threshold with broader biology demands
Higher glamour, broader consequence
Genome Research
Can be a cleaner home for genomics-heavy papers
More genomics-centered ownership
Genetics in Medicine
Better for clinically implemented genetics
More clinical-facing than field-flagship genetics

This is why frustration about AJHG timing is often really frustration about journal ownership. The paper may be publishable, but not necessarily publishable here.

What review-time data hides

Review-time discussion hides a few things that matter more than the clock:

  • the official 4-week target is a first-decision target, not a guarantee of acceptance or a total-cycle promise
  • the one-revision norm means invited revisions carry real pressure
  • early editorial rejection often means the paper was mispositioned, not that the process failed
  • reviewer speed matters less than whether the editors think the work belongs on the AJHG stage

Readiness check

While you wait on American Journal of Human Genetics, scan your next manuscript.

The scan takes about 1-2 minutes. Use the result to decide whether to revise before the decision comes back.

Check my next manuscriptAnthropic Privacy Partner. Zero-retention manuscript processing.Open status guideOr verify a citation in 10 seconds

In our pre-submission review work with AJHG manuscripts

The most common timing mistake is assuming that because AJHG is a society flagship, technically solid genetics work should naturally get a full review.

That is not how it works.

The papers that move best here usually have:

  • a broad human-genetics consequence visible in the title and abstract
  • a clear explanation of why the finding matters beyond one local specialty
  • stronger interpretation than raw association or cataloging alone
  • a field-facing package rather than a niche-facing one

Those traits improve timing because they make the editorial choice simpler.

What do pre-submission reviews reveal about The American Journal of Human Genetics (AJHG) review delays?

In our pre-submission review work on AJHG-targeted manuscripts, three patterns most consistently predict slow review at The American Journal of Human Genetics (AJHG). Of manuscripts we screened in 2025 targeting AJHG and peer venues, the patterns below are the same ones our reviewers flag in real time. The named editorial-culture quirk: AJHG reviewers expect patient-cohort data with documented IRB approval and explicit consent statements; missing IRB documentation gets returned at desk.

Scope-fit ambiguity in the abstract. AJHG editors move fastest on manuscripts whose contribution is obviously aligned with the journal's editorial scope (human-genetics research with patient-cohort data and translational implications). The named failure pattern: papers without documented IRB approval and explicit consent statements get returned at desk. Check whether your abstract reads to AJHG's scope →

Methods package incomplete for the journal's reviewer pool. AJHG reviewers expect specific methodological detail. Cohort studies without explicit population-stratification controls extend revision. Check if your methods package is reviewer-complete →

Reference-list and clean-citation failure mode. Editorial team at The American Journal of Human Genetics (AJHG) screens reference lists for retracted-paper inclusion. Check whether your reference list is clean against Crossref + Retraction Watch →

Submit If

  • The headline finding fits The American Journal of Human Genetics (AJHG)'s editorial scope (human-genetics research with patient-cohort data and translational implications) and the abstract names that fit within the first 100 words for AJHG's editorial-team triage.
  • The methods section is detailed enough for AJHG reviewers to evaluate without follow-up; protocol and reproducibility detail are in the main text rather than deferred to supplementary materials.
  • The reference list is clean of recently retracted citations.
  • A figure or table makes the contribution visible without specialist translation; the cover letter explicitly names the AJHG-relevant audience the work is aimed at.

Think Twice If

  • Papers without documented irb approval and explicit consent statements get returned at desk; this is the named AJHG desk-screen failure mode our team flags before submission.
  • The cover letter spends a paragraph on background before the new finding appears in the abstract; AJHG's editorial culture treats this as a scope-fit warning.
  • The reference list cites a paper that has since been retracted without acknowledging the retraction notice.
  • The protocol or methodology section relies on more than 3 figures of supplementary material that should be in the main text for AJHG's reviewer pool.

What should drive the submission decision instead

For AJHG, the better question is not only "how fast?" It is "does this look like flagship human genetics?"

That is why the better next reads are:

An AJHG fit check is usually more useful than fixating on the 4-week number alone.

Practical verdict

American Journal of Human Genetics review time is best understood as an officially disclosed within-4-weeks first-decision target sitting on top of a strong editorial fit screen. The journal is transparent enough to tell authors the front-end clock, but the real driver of speed is still whether the manuscript looks like broad human genetics from the first read.

The Manusights AJHG readiness scan. This guide tells you what American Journal of Human Genetics's editors look for in the first 1-2 weeks. The review tells you whether YOUR paper passes that check. We have reviewed manuscripts targeting American Journal of Human Genetics and peer venues; the patterns documented above are the same ones our reviewers flag in real time. 60-day money-back guarantee. We do not train AI on your manuscript and delete it within 24 hours.

Pre-submission checklist for AJHG

  • [ ] Abstract is within AJHG's 200-word limit and names the contribution within the first 100 words
  • [ ] Cover letter explicitly addresses human-genetics research with patient-cohort data and translational implications in the first paragraph (not buried in background)
  • [ ] All cited DOIs verified clean against Crossref + Retraction Watch
  • [ ] Methods section is detailed enough that AJHG reviewers can evaluate without follow-up; supplementary materials supplement, not replace, main-text methodology
  • [ ] Reviewer-suggestion list contains 5 names from at least 3 different institutions, all active in the AJHG reviewer pool
  • [ ] Submission portal account active at https://www.editorialmanager.com/ajhg/; ORCID linked if applicable
  • [ ] Data-availability and code-availability statements name the actual repository (DOI or URL); 'available on request' is not accepted at AJHG
  • [ ] Reference list reflects current state of the field within the last 18 months and matches AJHG's ajhg reviewers expect patient-cohort data with documented irb approval and explicit consent statements

Frequently asked questions

AJHG says the editors make every effort to reach decisions within 4 weeks of submission. That is the clearest official timing signal authors have for the first decision.

The official ASHG page says manuscripts that meet the general publication criteria are sent to at least two reviewers who have agreed in advance to assess the paper rapidly.

Yes. The same official language says all submissions are evaluated in depth by the editors first, so manuscripts that do not clear the journal's broad human-genetics bar can stop before or at the first reviewer-selection stage.

Field-level fit is the biggest variable. Papers that clearly matter to a broad human-genetics readership move more cleanly than papers that are mainly narrow clinical reporting, narrow methods work, or model-organism studies with only indirect human relevance.

References

Sources

  1. ASHG: The American Journal of Human Genetics
  2. ASHG 2024-2025 Annual Report
  3. AJHG submission system
  4. Resurchify: American Journal of Human Genetics

Best next step

Use this page to interpret the status and choose the next sensible move.

For American Journal of Human Genetics, the better next step is guidance on timing, follow-up, and what to do while the manuscript is still in the system. Save the Free Readiness Scan for the next paper you have not submitted yet.

Guidance first. Use the scan for the next manuscript.

Anthropic Privacy Partner. Zero-retention manuscript processing.

Internal navigation

Where to go next

Open Status Guide